Shreehas Tambe appointed as MD & CEO of Biocon Biologics
Tambe has taken over from Arun Chandavarkar, who continues to serve as a non-Executive, non-Independent Director on the Board of Biocon Biologics
Stay updated with breaking news from Biocon Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tambe has taken over from Arun Chandavarkar, who continues to serve as a non-Executive, non-Independent Director on the Board of Biocon Biologics
Biocon Biologics Ltd., a subsidiary of Biocon Ltd, announced today that it has successfully completed its multi-billion-dollar acquisition of the global biosimilars business of its partner Viatris Inc.
Bengaluru (Karnataka) [India], November 15 (ANI/NewsVoir): Biocon Ltd. (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, today announced its consolidated financial results for the second quarter ended September 30, 2022. Leadership Comments Biocon Group "We reported a strong consolidated revenue growth of 23 per cent YoY for Q2FY23 at Rs. 2,384 Crore driven by 34 per cent growth in Biosimilars, 26 per cent in Research Services and 18 per cent in the Generics business. Our Gross R&D spends increased by 52 per cent YoY this quarter to Rs. 252 Crore re...
A record 80 organisations around the Asia-Pacific region featured in this year's event, which was organized after a gap of two years.
Hyderabad: Commemorating World Science Day, Syngene International Ltd., an integrated research, development and manufacturing services company, and the Research and Innovation Circle of Hyderabad (RICH), announced the launch of a program to support women studying science, technology, engineering and maths.